These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 15279402)

  • 1. Pharmacological treatment of dementia.
    Santaguida PS; Raina P; Booker L; Patterson C; Baldassarre F; Cowan D; Gauld M; Levine M; Unsal A
    Evid Rep Technol Assess (Summ); 2004 Apr; (97):1-16. PubMed ID: 15279402
    [No Abstract]   [Full Text] [Related]  

  • 2. Drugs influencing cognitive function.
    Kuruvilla A; Devi V
    Indian J Physiol Pharmacol; 1994 Oct; 38(4):241-51. PubMed ID: 7883287
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacologic treatment of cognition in Alzheimer's dementia.
    Farlow MR; Evans RM
    Neurology; 1998 Jul; 51(1 Suppl 1):S36-44; discussion S65-7. PubMed ID: 9674761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacological rationale for treating vascular dementia with galantamine (Reminyl).
    Maelicke A
    Int J Clin Pract Suppl; 2001 May; (120):24-8. PubMed ID: 11406923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacological treatment of vascular cognitive impairment].
    Bidzan L
    Przegl Lek; 2006; 63(3):131-3. PubMed ID: 16969897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The use of reminyl (galantamine) in the treatment of probable vascular dementia].
    Mokhova OI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(9):77-9. PubMed ID: 19911468
    [No Abstract]   [Full Text] [Related]  

  • 7. Vascular dementia: pharmacological treatment approaches and perspectives.
    Baskys A; Hou AC
    Clin Interv Aging; 2007; 2(3):327-35. PubMed ID: 18044183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cognitive enhancement effect of piracetam in patients with mild cognitive impairment and dementia].
    Tariska P; Paksy A
    Orv Hetil; 2000 May; 141(22):1189-93. PubMed ID: 10853348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholinesterase inhibitors in the treatment of Alzheimer's disease and related dementias.
    Masterman D
    Clin Geriatr Med; 2004 Feb; 20(1):59-68. PubMed ID: 15062487
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of vascular dementia-evidence from clinical trials with cholinesterase inhibitors.
    Erkinjuntti T; Román G; Gauthier S
    Neurol Res; 2004 Jul; 26(5):603-5. PubMed ID: 15265282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The brain cholinergic system as a target of cognition enhancers.
    Giovannini MG; Casamenti F; Bartolini L; Pepeu G
    Behav Brain Res; 1997 Feb; 83(1-2):1-5. PubMed ID: 9062653
    [No Abstract]   [Full Text] [Related]  

  • 12. Drugs for cognitive loss and dementia.
    Treat Guidel Med Lett; 2010 Mar; 8(91):19-24. PubMed ID: 20179667
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of cholinergic drugs and cognitive training on dementia.
    Requena C; López Ibor MI; Maestú F; Campo P; López Ibor JJ; Ortiz T
    Dement Geriatr Cogn Disord; 2004; 18(1):50-4. PubMed ID: 15084794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dementia: etiology, diagnosis, treatment].
    Zakharov VV
    Ter Arkh; 2007; 79(8):85-8. PubMed ID: 17926478
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of galantamine to treat vascular dementia.
    Moretti R; Torre P; Antonello RM; Cazzato G; Bava A
    Lancet; 2002 Nov; 360(9344):1512-3; author reply 1513. PubMed ID: 12433549
    [No Abstract]   [Full Text] [Related]  

  • 16. [Influence of aniracetam on the learning ability, memory ability and the expression of BCL-2 of hippocampal in vascular dementia model rats].
    Pan Y; Dai T; Yang Q
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2009 May; 25(2):180-1, 227. PubMed ID: 21189545
    [No Abstract]   [Full Text] [Related]  

  • 17. Galantamine versus risperidone for agitation in people with dementia: a randomized, twelve-week, single-center study.
    Freund-Levi Y; Bloniecki V; Auestad B; Tysen Bäckström AC; Lärksäter M; Aarsland D
    Dement Geriatr Cogn Disord; 2014; 38(3-4):234-44. PubMed ID: 24969380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [EEG and clinical psychophysiological study of functional changes in the chronic ischemic brain with increased acetylcholinergic activity].
    Sorokina ND; Selitskiĭ GV; Kositsyn NS
    Fiziol Cheloveka; 2007; 33(3):35-9. PubMed ID: 17619614
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antidementia drugs].
    Müller-Spahn F; Sollberger D; Wollmer MA
    Ther Umsch; 2009 Jun; 66(6):432-40. PubMed ID: 19496039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nootropics: pharmacological properties and therapeutic use.
    Gabryel B; Trzeciak HI
    Pol J Pharmacol; 1994; 46(5):383-94. PubMed ID: 7894524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.